List of Flash News about Eli Lilly LLY
Time | Details |
---|---|
2025-08-04 20:11 |
Top 5 Rule of 80 Frontier Stocks: Nvidia (NVDA), Palantir (PLTR), Eli Lilly (LLY), TSM, and Visa (V) Showcase Strong Performance
According to @StockMKTNewz, Palantir (PLTR) has highlighted the 'rule of 80 Frontier,' ranking the top five stocks by their respective growth metrics: Nvidia (NVDA) leads with 122%, followed by Palantir (PLTR) at 94%, Eli Lilly (LLY) at 89%, Taiwan Semiconductor (TSM) at 88%, and Visa (V) at 83%. This ranking demonstrates the continued dominance of AI, semiconductor, and financial sector equities in driving equity market returns. For crypto traders, the strong performance of NVDA and TSM may signal ongoing demand for AI and blockchain infrastructure, potentially influencing crypto market sentiment and investment flows. Source: @StockMKTNewz |
2025-06-18 12:23 |
CRISPR Therapeutics (CRSP) Reiterated 'Outperform' at Citizens JMP with $86 Target After Gene-Editing M&A Milestone
According to Stock Talk (@stocktalkweekly), Citizens JMP has reiterated its 'Outperform' rating on CRISPR Therapeutics (CRSP) and set an $86 price target, following a significant gene-editing M&A deal that marks a major milestone for the technology. The report highlights recent collaborations between Eli Lilly (LLY) and Verve Therapeutics (VERV), noting growing institutional confidence in gene-editing's commercial potential. For crypto traders, the surge in biotech M&A and institutional adoption of advanced gene-editing technologies could boost market sentiment for blockchain projects focusing on healthcare or biotech tokenization, creating new cross-sector momentum. (Source: Stock Talk on Twitter, June 18, 2025) |